Brussels, 09/03/2016 (Agence Europe) - The European Parliament is not opposed to the codification of different regulations to prevent the misappropriation of certain essential medicines to countries in the European Union. This was decided during a plenary session vote on the report by Laura Ferrara (EFDD, Italy), held on Wednesday 9 March.
In May 2014, the European Commission presented a draft regulation to prevent medicines sold in developing countries for lower prices (“differentiated price rates”) re-emerging on the European market at the same prices. The document does not contain any subsequent innovation and simply codifies, without amending, the following regulations: 953/2003, 1876/2004 and 1662/2005 relating to the fight against the misappropriation of medicines and regulation 38/2014 on the powers delegated to the Commission in this domain. Overall, it covers HIV/AIDS medicines, as well as those for malaria, tuberculosis and other sporadic related diseases. It sets out criteria for defining: -a product subject to differentiated prices; -the circumstances in which the customs authorities can take measures and the measures adopted by the competent national authorities. (Original version in French by Sophie Petitjean)